Please select the option that best describes you:

Is the COVID-19 pandemic affecting your choice of high dose versus weekly cisplatin for definitive concurrent chemoradiation for HPV negative head and neck cancer?  



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more